|
|
||||||||
The Journal of Immunology, Vol 137, Issue 7 2215-2219, Copyright © 1986 by American Association of Immunologists
ARTICLES |
J Mizuguchi, MA Beaven, J Ohara and WE Paul
B cell stimulatory factor-1 (BSF-1) acts on resting B cells to increase expression of class II major histocompatibility complex (MHC) molecules and to prepare for more prompt entry into S phase in response to anti- IgM and lipopolysaccharide. It also acts as a costimulant, with low concentrations of anti-IgM, to cause resting B cells to synthesize DNA. Unlike anti-IgM, BSF-1 does not cause elevation in inositol phospholipid metabolism or in concentration of intracellular free calcium, nor does it enhance such biochemical responses to anti-IgM. Furthermore, increased expression of class II MHC molecules to BSF-1 is observed when essentially all extracellular calcium is chelated by EGTA, whereas lower concentrations of EGTA completely inhibit increases in class II molecules in response to anti-IgM. These results indicate that BSF-1 effects on resting B cells are not mediated by the inositol phospholipid metabolic pathway.
This article has been cited by other articles:
![]() |
M. J. Welham, L. Learmonth, H. Bone, and J. W. Schrader Interleukin-13 Signal Transduction in Lymphohemopoietic Cells J. Biol. Chem., May 19, 1995; 270(20): 12286 - 12296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.G.B. Klaus, M.M. Harnett, and K.P. Rigley Regulation of the Polyphosphoinositide-specific Phosphodiesterase in B Lymphocytes Cold Spring Harb Symp Quant Biol, January 1, 1989; 54(0): 723 - 731. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |